Loading…

A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization

The terms “agglomerate” and “aggregate” are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 2002-10, Vol.91 (10), p.2103-2109
Main Authors: Nichols, Gary, Byard, Stephen, Bloxham, Mark J., Botterill, Joanne, Dawson, Neil J., Dennis, Andrew, Diart, Valerie, North, Nigel C., Sherwood, John D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3
cites cdi_FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3
container_end_page 2109
container_issue 10
container_start_page 2103
container_title Journal of pharmaceutical sciences
container_volume 91
creator Nichols, Gary
Byard, Stephen
Bloxham, Mark J.
Botterill, Joanne
Dawson, Neil J.
Dennis, Andrew
Diart, Valerie
North, Nigel C.
Sherwood, John D.
description The terms “agglomerate” and “aggregate” are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in universal confusion. This confusion is perpetuated by conflicting definitions in national and international standards and this presents problems when describing powder properties or communicating results in reports and research papers. This paper reviews the current status of the definitions, with particular emphasis on their use in the pharmaceutical industry. It is proposed that just one term, agglomerate, should be used to describe an assemblage of particles in a powder and that the term aggregate should be confined to pre‐nucleation structures. © 2002 Wiley‐Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:2103–2109, 2002
doi_str_mv 10.1002/jps.10191
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72084643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916310942</els_id><sourcerecordid>72084643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3</originalsourceid><addsrcrecordid>eNp1kUFvEzEQhS0EomngwB9AvoDUw1J7vWvvHtO0lKKoRNCKo-XYs4nL7jrYDqFc-eN1soFe4GSP5nvzNG8QekXJO0pIfnq3DulDa_oEjWiZk4wTKp6iUerlGSuL-ggdh3BHCOGkLJ-jI5rnOa-YGKHfE_wZfljYYtfguAJ8A74LeLJctq4DryJg1Ztd7WG5q7Y2rrBKIu26DnqjonU9bpzH10nQ61bFjQd8G8Bg2-O52xrw-xlz5aPVLeDpSnmlI3j7a69-gZ41qg3w8vCO0e37i5vph2z26fJqOpllumCMZiAYM6ChKkmtC0MXhIMqgOoFobrOOU8N0Mwo2hCxKDVhhJK61CInRlAwbIzeDnPX3n3fQIiys0FD26oe3CbIBFYFT15jdDKA2rsQPDRy7W2n_L2kRO4SlylxuU88sa8PQzeLDswjeYg4AW8OgApatY1XvbbhkWN1IXhyHaPTgdvaFu7_7yg_zr_8sc4GhQ0Rfv5VKP9NcsFEKb9eX0rGZrQ-r85klXg28JBCTjf3MmibTgbGetBRGmf_seADJNS40Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72084643</pqid></control><display><type>article</type><title>A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization</title><source>Wiley Online Library</source><source>ScienceDirect Journals</source><creator>Nichols, Gary ; Byard, Stephen ; Bloxham, Mark J. ; Botterill, Joanne ; Dawson, Neil J. ; Dennis, Andrew ; Diart, Valerie ; North, Nigel C. ; Sherwood, John D.</creator><creatorcontrib>Nichols, Gary ; Byard, Stephen ; Bloxham, Mark J. ; Botterill, Joanne ; Dawson, Neil J. ; Dennis, Andrew ; Diart, Valerie ; North, Nigel C. ; Sherwood, John D.</creatorcontrib><description>The terms “agglomerate” and “aggregate” are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in universal confusion. This confusion is perpetuated by conflicting definitions in national and international standards and this presents problems when describing powder properties or communicating results in reports and research papers. This paper reviews the current status of the definitions, with particular emphasis on their use in the pharmaceutical industry. It is proposed that just one term, agglomerate, should be used to describe an assemblage of particles in a powder and that the term aggregate should be confined to pre‐nucleation structures. © 2002 Wiley‐Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:2103–2109, 2002</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.10191</identifier><identifier>PMID: 12226837</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>agglomerate ; aggregate ; Biological and medical sciences ; Drug Compounding ; Excipients ; General pharmacology ; Medical sciences ; nomenclature ; particle assemblage ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; powder characterization ; powder properties ; Powders - classification ; Suspensions ; Terminology as Topic</subject><ispartof>Journal of pharmaceutical sciences, 2002-10, Vol.91 (10), p.2103-2109</ispartof><rights>2002 Wiley-Liss, Inc. and the American Pharmaceutical Association</rights><rights>Copyright © 2002 Wiley‐Liss, Inc. and the American Pharmaceutical Association</rights><rights>2003 INIST-CNRS</rights><rights>Copyright 2002 Wiley-Liss Inc. and the American Pharmaceutical Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3</citedby><cites>FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.10191$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354916310942$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13947664$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12226837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nichols, Gary</creatorcontrib><creatorcontrib>Byard, Stephen</creatorcontrib><creatorcontrib>Bloxham, Mark J.</creatorcontrib><creatorcontrib>Botterill, Joanne</creatorcontrib><creatorcontrib>Dawson, Neil J.</creatorcontrib><creatorcontrib>Dennis, Andrew</creatorcontrib><creatorcontrib>Diart, Valerie</creatorcontrib><creatorcontrib>North, Nigel C.</creatorcontrib><creatorcontrib>Sherwood, John D.</creatorcontrib><title>A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The terms “agglomerate” and “aggregate” are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in universal confusion. This confusion is perpetuated by conflicting definitions in national and international standards and this presents problems when describing powder properties or communicating results in reports and research papers. This paper reviews the current status of the definitions, with particular emphasis on their use in the pharmaceutical industry. It is proposed that just one term, agglomerate, should be used to describe an assemblage of particles in a powder and that the term aggregate should be confined to pre‐nucleation structures. © 2002 Wiley‐Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:2103–2109, 2002</description><subject>agglomerate</subject><subject>aggregate</subject><subject>Biological and medical sciences</subject><subject>Drug Compounding</subject><subject>Excipients</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>nomenclature</subject><subject>particle assemblage</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>powder characterization</subject><subject>powder properties</subject><subject>Powders - classification</subject><subject>Suspensions</subject><subject>Terminology as Topic</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp1kUFvEzEQhS0EomngwB9AvoDUw1J7vWvvHtO0lKKoRNCKo-XYs4nL7jrYDqFc-eN1soFe4GSP5nvzNG8QekXJO0pIfnq3DulDa_oEjWiZk4wTKp6iUerlGSuL-ggdh3BHCOGkLJ-jI5rnOa-YGKHfE_wZfljYYtfguAJ8A74LeLJctq4DryJg1Ztd7WG5q7Y2rrBKIu26DnqjonU9bpzH10nQ61bFjQd8G8Bg2-O52xrw-xlz5aPVLeDpSnmlI3j7a69-gZ41qg3w8vCO0e37i5vph2z26fJqOpllumCMZiAYM6ChKkmtC0MXhIMqgOoFobrOOU8N0Mwo2hCxKDVhhJK61CInRlAwbIzeDnPX3n3fQIiys0FD26oe3CbIBFYFT15jdDKA2rsQPDRy7W2n_L2kRO4SlylxuU88sa8PQzeLDswjeYg4AW8OgApatY1XvbbhkWN1IXhyHaPTgdvaFu7_7yg_zr_8sc4GhQ0Rfv5VKP9NcsFEKb9eX0rGZrQ-r85klXg28JBCTjf3MmibTgbGetBRGmf_seADJNS40Q</recordid><startdate>200210</startdate><enddate>200210</enddate><creator>Nichols, Gary</creator><creator>Byard, Stephen</creator><creator>Bloxham, Mark J.</creator><creator>Botterill, Joanne</creator><creator>Dawson, Neil J.</creator><creator>Dennis, Andrew</creator><creator>Diart, Valerie</creator><creator>North, Nigel C.</creator><creator>Sherwood, John D.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200210</creationdate><title>A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization</title><author>Nichols, Gary ; Byard, Stephen ; Bloxham, Mark J. ; Botterill, Joanne ; Dawson, Neil J. ; Dennis, Andrew ; Diart, Valerie ; North, Nigel C. ; Sherwood, John D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>agglomerate</topic><topic>aggregate</topic><topic>Biological and medical sciences</topic><topic>Drug Compounding</topic><topic>Excipients</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>nomenclature</topic><topic>particle assemblage</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>powder characterization</topic><topic>powder properties</topic><topic>Powders - classification</topic><topic>Suspensions</topic><topic>Terminology as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nichols, Gary</creatorcontrib><creatorcontrib>Byard, Stephen</creatorcontrib><creatorcontrib>Bloxham, Mark J.</creatorcontrib><creatorcontrib>Botterill, Joanne</creatorcontrib><creatorcontrib>Dawson, Neil J.</creatorcontrib><creatorcontrib>Dennis, Andrew</creatorcontrib><creatorcontrib>Diart, Valerie</creatorcontrib><creatorcontrib>North, Nigel C.</creatorcontrib><creatorcontrib>Sherwood, John D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nichols, Gary</au><au>Byard, Stephen</au><au>Bloxham, Mark J.</au><au>Botterill, Joanne</au><au>Dawson, Neil J.</au><au>Dennis, Andrew</au><au>Diart, Valerie</au><au>North, Nigel C.</au><au>Sherwood, John D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2002-10</date><risdate>2002</risdate><volume>91</volume><issue>10</issue><spage>2103</spage><epage>2109</epage><pages>2103-2109</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>The terms “agglomerate” and “aggregate” are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in universal confusion. This confusion is perpetuated by conflicting definitions in national and international standards and this presents problems when describing powder properties or communicating results in reports and research papers. This paper reviews the current status of the definitions, with particular emphasis on their use in the pharmaceutical industry. It is proposed that just one term, agglomerate, should be used to describe an assemblage of particles in a powder and that the term aggregate should be confined to pre‐nucleation structures. © 2002 Wiley‐Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:2103–2109, 2002</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>12226837</pmid><doi>10.1002/jps.10191</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2002-10, Vol.91 (10), p.2103-2109
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_72084643
source Wiley Online Library; ScienceDirect Journals
subjects agglomerate
aggregate
Biological and medical sciences
Drug Compounding
Excipients
General pharmacology
Medical sciences
nomenclature
particle assemblage
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
powder characterization
powder properties
Powders - classification
Suspensions
Terminology as Topic
title A Review of the Terms Agglomerate and Aggregate with a Recommendation for Nomenclature Used in Powder and Particle Characterization
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A21%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Review%20of%20the%20Terms%20Agglomerate%20and%20Aggregate%20with%20a%20Recommendation%20for%20Nomenclature%20Used%20in%20Powder%20and%20Particle%20Characterization&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Nichols,%20Gary&rft.date=2002-10&rft.volume=91&rft.issue=10&rft.spage=2103&rft.epage=2109&rft.pages=2103-2109&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.10191&rft_dat=%3Cproquest_cross%3E72084643%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4331-e733dece8509c4d1b06ea4e1cb01c9266850ec3da1f07b5c0301095c720d71ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72084643&rft_id=info:pmid/12226837&rfr_iscdi=true